Trial Profile
PCSK9 Inhibitor: a New Tool to Fight Septic Shock
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Alirocumab (Primary)
- Indications Septic shock
- Focus Therapeutic Use
- 23 Aug 2018 New trial record